Far too many seniors face an impossible choice: pay for prescription drugs, or purchase other necessities. Roughly one in every five seniors has recently declined or delayed filling a prescription, skipped a dose or split pills because of the cost.
President Donald Trump recently floated two proposals to tackle this affordability crisis. Both are well-intentioned. But one could easily backfire and deprive seniors of lifesaving medicines, while the other would help solve the problem with virtually no downsides.
Patients are counting on the president to choose wisely.
That first plan, which the White House has dubbed its "Most-Favored-Nation" proposal, could cap U.S. drug prices at the levels that prevail in European countries with socialized health care systems. In those countries, drug